Help
RSS
API
Feed
Maltego
Contact
Domain > www.rozlytrek-hcp.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-09-18
104.18.31.3
(
ClassC
)
2025-01-16
104.18.30.3
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Sat, 08 Jun 2024 23:11:03 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Sun, 09 Jun 2024 00:11:03 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sat, 08 Jun 2024 23:11:03 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-alivevary: Accept-EncodingCF-Cache-Status: DYNAMICSet-Cookie: __cf_bmP !DOCTYPE HTML>html langen-US> head> meta charsetUTF-8/> title>ROZLYTREK (entrectinib) ROS1 & TRK Inhibitor | HCP/title> meta namedescription contentLearn about ROZLYTREK (entrectinib), an FDA-approved treatment option for patients with ROS1+ mNSCLC and certain NTRK fusion+ solid tumors. See full Prescribing Information for Important Safety Information./> meta nametemplate contentflexible-page/> meta nameviewport contentwidthdevice-width, initial-scale1/> link relcanonical hrefhttps://www.rozlytrek-hcp.com//> meta propertyog:site_name contentrozlytrek/> meta propertyog:type contentwebsite/> meta propertyog:locale contenten_US/> meta propertyog:title contentROZLYTREK (entrectinib) ROS1 & TRK Inhibitor | HCP/> meta propertyog:description contentLearn about ROZLYTREK (entrectinib), an FDA-approved treatment option for patients with ROS1+ mNSCLC and certain NTRK fusion+ solid tumors. See full Prescribing Information for Important Safety Information./> meta propertyog:url contenthttps://www.rozlytrek-hcp.com//> meta propertyog:image contenthttps://www.rozlytrek-hcp.com/content/dam/gene/rozlytrek-hcp/global/Global_Product_logo.genecoreimg.1200.png/> meta propertyog:image:type contentimage/png/> meta propertyog:image:width content220/> meta propertyog:image:height content87/> meta propertyog:image:alt contentROZLYTREK (entrectinib) ROS1 & TRK Inhibitor/> meta nametwitter:card contentsummary_large_image/> link relicon typeimage/x-icon href/content/dam/gene/rozlytrek-hcp/global/entrectinib_favicon.png/> link relshortcut icon typeimage/x-icon href/content/dam/gene/rozlytrek-hcp/global/entrectinib_favicon.png/> link hrefhttps://fonts.googleapis.com/css2?familyOpen+Sans:ital,wght@0,400;0,700;1,400;1,700&displayswap relstylesheet/> script typetext/plain classoptanon-category-C0002> window.NREUM||(NREUM{}),__nr_requirefunction(t,n,e){function r(e){if(!ne){var one{exports:{}};te0.call(o.exports,function(n){var
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]